neuropathiazol,
Neuropathiazol,
880090-88-0,
Ethyl 4-(methyl(2-phenylthiazol-4-yl)amino)benzoate,
KHS2,
ethyl 4-[methyl(2-phenyl-1,3-thiazol-4-yl)amino]benzoate,
AK-48564,
C19H18N2O2S,
Neuropathiazole,
Neuropathiazol/,
SCHEMBL8238620,
CTK8B5416,
KS-00001CST,
DTXSID80470323,
BCPP000150,
BCP02467,
ABP000753,
ANW-48675,
IN1203,
MFCD09951983,
ZINC38214379,
AKOS015919526,
BCP9000986,
CS-3112,
GS-3918,
QC-8217,
NCGC00386753-04,
AJ-94661,
BR-48564,
CJ-19163,
DA-17350,
HY-10591,
AB0008126,
AX8211960,
TC-137420,
4CH-010350,
FT-0727742,
ST24024930,
W9032,
A14058,
S-7623,
Ethyl 4-[methyl-(2-phenyl-1,3-thiazol-4-yl)amino]benzoate,
ACN-052769,
CID11667240,
B4656,
Benzoic acid, 4-[methyl(2-phenyl-4-thiazolyl)amino]-, ethyl ester,